Vicore Pharmaceuticals has carried out directed new share issues and is raising gross proceeds of SEK 500 million. Read moreThe company calls an extraordinary general meeting. Read more.

Iconovo initiates collaboration with Danish company to develop a new inhalable treatment for rare disease. Read more.

Positive results in AstraZeneca phase III study ALPHA. Read more.

AstraZeneca has also entered into a collaboration with Quell Therapeutics regarding T-reg cell therapies. Read moreThe company also issues a unanimous positive opinion for Niversimab by the FDA Advisory Committee. Read more.

Coegin announces timetable for share reverse split. Read more.

Faron Pharmaceuticals presents new biomarker data from BEXMAB vid AND HAS today June 9th. Read more.

Nanexa has completed the planned recruitment for the Phase I study of NEX-20. Read more.

Genmab announces data for Epcoritamab in patients with B-cell lymphoma. Read more.

SoftOx Solutions has raised capital and reached agreements with creditors. Read more.

Pipeline update announced by Gubra. Read more.

Nexstim receives an order regarding NBS 5+ system from a customer in the USA. Read more.

Hamlet Pharma will present at the Swedish Shareholders' Association's Capital Markets Day on June 12. Read more.

The first trading day for Brain+ new shares and warrants are on June 13. Read more.

See last week's BioStock Life Science Spring Summit via the banner below:

Invitations:

Lipidor  Lipum  WntResearch

Communiqués:

CLS  Idogen  S2Medical

Flagging, insider trading, changes in equity:

BergenBio  Immunovia  Revenio Group  Ultimovacs  Zealand Pharma

News since Thursday lunch

BPC Instruments expanding into Southeast Asia through newly launched business accelerator program. Read more.

Aptahem participates in the Small Business Association's Small Business Days on June 12. Read more.

Lipigon has announced notice of allowance regarding American Lipisense-patent. Read more.

Positive results in ALK-Abellós phase III study in HDM-induced allergic rhinitis. Read more.

S2Medical has signed a manufacturing agreement with a distributor in Saudi Arabia. Read more.

Kiwok Nordic carries out a new share issue with preferential rights for current shareholders. Read more.

Peptonic Medical has won an arbitration award in China. Read more.

Proby begins partnership with Classed for the development of synbiotics. Read more.

Calmark has announced changes in management. Read more.

Allocation of restricted shares and warrants to employees in Genmab. Read more.

Modern pharmaceutical law welcomed, says Life vd Johan Farnstrand. Read more.

This morning's price development